Wednesday, November 20, 2019

CanBio Bagel Talk

9:00 AM to 10:00 AM

Med Sci I, C-Wing, room 3114.

Contact Kurt Nelson

Wenyi Wei, PhD, Professor of Pathology, Harvard Medical School

Speaking on: Targeting Cell Signaling Pathways for Cancer Therapies.

Wenyi Wei

Wenyi Wei, PhD

Professor of Pathology, Harvard Medical School

Dr. Wenyi Wei is a professor of Pathology at Harvard Medical School and the Beth Israel Deacones Medical Center. He received his B.A. degree from Shandong University in 1993 and then obtained his M.S. training in Chinese Academy of Science from 1993 to 1996. Afterwards, Dr. Wei received his Ph.D. training in the MCB department at Brown University and his postdoctoral training in the laboratory of Dr. William Kaelin, Jr. at DFCI, Harvard Medical School. Dr. Wei became formed his own laboratory in 2006 in Department Pathology at Beth Israel Deaconess Medical Center, Harvard Medical School. The major focus of the WEI laboratory is aimed at understanding how aberrant cell signaling events contribute to cell cycle dysregulation and subsequent tumorigenesis, which will offer the molecular basis and the rationale to develop novel anti-cancer therapies targeting specific cell signaling pathways.